Clinical trial

Efficacy and Safety Study of the Combined Oral Contraceptive NOMAC-E2 Compared…

NCT00413062 · Organon and Co, Industry · Completed

Key facts

NCT number NCT00413062
Title Efficacy and Safety Study of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292002)(P05722)
Official title A Randomized, Open-Label, Comparative, Multi -Center Trial to Evaluate Contraceptive Efficacy, Cycle Control, Safety and Acceptability of a Monophasic Combined Oral Contraceptive (COC) Containing 2.5 mg Nomegestrol Acetate (NOMAC) and 1.5 mg Estradiol (E2), Compared to a Monophasic COC Containing 3…
Lead sponsor Organon and Co, Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Contraception
Intervention type Drug
Interventions NOMAC-E2, DRSP-EE
Enrollment 2,281
Start date Jun 1, 2006
Primary completion Aug 1, 2008
Completion Aug 1, 2008
First posted Dec 19, 2006
Last update posted Feb 9, 2022

At a glance

  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies